OraSure Technologies - 39 Year Stock Price History | OSUR
Historical daily share price chart and data for OraSure Technologies since 1986 adjusted for splits and dividends. The latest closing stock price for OraSure Technologies as of July 14, 2025 is 3.07.
- The all-time high OraSure Technologies stock closing price was 27.00 on January 15, 1992.
- The OraSure Technologies 52-week high stock price is 4.92, which is 60.3% above the current share price.
- The OraSure Technologies 52-week low stock price is 2.36, which is 23.1% below the current share price.
- The average OraSure Technologies stock price for the last 52 weeks is 3.67.
| OraSure Technologies Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 3.2613 | 3.5400 | 4.1100 | 2.4300 | 3.0700 | -14.96% |
| 2024 | 5.1314 | 8.2800 | 8.2800 | 3.5800 | 3.6100 | -55.98% |
| 2023 | 5.9551 | 4.7900 | 8.3500 | 4.4000 | 8.2000 | 70.12% |
| 2022 | 5.2737 | 8.6600 | 9.3300 | 2.7100 | 4.8200 | -44.53% |
| 2021 | 10.6955 | 11.2100 | 15.4200 | 8.3000 | 8.6900 | -17.90% |
| 2020 | 11.7626 | 7.8900 | 19.5800 | 5.5700 | 10.5850 | 31.82% |
| 2019 | 9.1443 | 11.6700 | 13.0900 | 6.5700 | 8.0300 | -31.25% |
| 2018 | 16.3639 | 19.2900 | 22.0400 | 10.5300 | 11.6800 | -38.07% |
| 2017 | 15.7649 | 8.7900 | 22.8100 | 8.4800 | 18.8600 | 114.81% |
| 2016 | 7.2931 | 6.3500 | 9.3700 | 5.1800 | 8.7800 | 36.34% |
| 2015 | 6.3313 | 9.9500 | 10.5200 | 4.4400 | 6.4400 | -36.49% |
| 2014 | 7.7533 | 6.4700 | 10.5300 | 5.5300 | 10.1400 | 61.21% |
| 2013 | 5.4950 | 7.2500 | 7.3700 | 3.7900 | 6.2900 | -12.40% |
| 2012 | 10.0598 | 9.5100 | 13.3800 | 6.6900 | 7.1800 | -21.19% |
| 2011 | 8.0305 | 6.0100 | 9.9900 | 6.0100 | 9.1100 | 58.43% |
| 2010 | 4.8892 | 5.2900 | 6.7700 | 3.2500 | 5.7500 | 13.19% |
| 2009 | 3.1957 | 3.6600 | 5.1900 | 2.2500 | 5.0800 | 38.04% |
| 2008 | 5.3908 | 8.7200 | 9.1100 | 2.4300 | 3.6800 | -58.61% |
| 2007 | 8.5124 | 8.1500 | 10.5200 | 7.0400 | 8.8900 | 7.63% |
| 2006 | 8.8516 | 9.1200 | 11.5000 | 6.2500 | 8.2600 | -6.35% |
| 2005 | 8.8832 | 6.6000 | 13.9400 | 5.4300 | 8.8200 | 31.25% |
| 2004 | 7.6589 | 7.9200 | 10.5000 | 5.2000 | 6.7200 | -15.58% |
| 2003 | 7.7248 | 5.6400 | 10.7900 | 5.3800 | 7.9600 | 46.06% |
| 2002 | 5.9591 | 12.2000 | 12.2000 | 3.6500 | 5.4500 | -55.14% |
| 2001 | 10.1889 | 7.5313 | 14.7400 | 6.5000 | 12.1500 | 47.27% |
| 2000 | 10.8317 | 6.4375 | 17.0000 | 5.8750 | 8.2500 | 26.92% |
| 1999 | 5.6114 | 6.0000 | 7.8750 | 4.0000 | 6.5000 | 10.64% |
| 1998 | 5.3125 | 5.3750 | 6.8750 | 3.0000 | 5.8750 | 17.50% |
| 1997 | 8.7381 | 12.1250 | 16.2500 | 4.5000 | 5.0000 | -56.52% |
| 1996 | 15.5261 | 15.2500 | 21.5000 | 11.1250 | 11.5000 | -30.30% |
| 1995 | 15.5521 | 21.2500 | 21.2500 | 9.8750 | 16.5000 | -22.81% |
| 1994 | 18.1949 | 20.5000 | 24.8750 | 14.0000 | 21.3750 | 4.91% |
| 1993 | 19.4373 | 19.1250 | 23.6250 | 16.2500 | 20.3750 | 13.19% |
| 1992 | 19.6014 | 22.8750 | 27.0000 | 15.2500 | 18.0000 | -21.31% |
| 1991 | 17.6440 | 9.6250 | 26.0000 | 8.5000 | 22.8750 | 134.62% |
| 1990 | 7.2681 | 6.1250 | 9.8750 | 5.1250 | 9.7500 | 59.18% |
| 1989 | 6.5694 | 7.3750 | 9.6250 | 5.1250 | 6.1250 | -16.95% |
| 1988 | 7.7226 | 7.2500 | 10.1250 | 6.3750 | 7.3750 | 22.92% |
| 1987 | 7.5184 | 1.9375 | 11.7500 | 1.8333 | 6.0000 | 216.49% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.232B | $0.186B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.693B | 27.62 |
| Boston Scientific (BSX) | United States | $152.679B | 38.22 |
| Stryker (SYK) | United States | $148.653B | 31.08 |
| EssilorLuxottica (ESLOY) | France | $131.422B | 0.00 |
| Medtronic (MDT) | Ireland | $115.326B | 16.35 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.666B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.744B | 25.54 |
| ResMed (RMD) | United States | $37.302B | 28.02 |
| Agilent Technologies (A) | United States | $35.020B | 22.83 |
| GE HealthCare Technologies (GEHC) | United States | $34.401B | 16.33 |
| Terumo (TRUMY) | Japan | $24.607B | 31.96 |
| Koninklijke Philips (PHG) | Netherlands | $23.139B | 16.24 |
| Insulet (PODD) | United States | $20.361B | 79.92 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.556B | 11.92 |
| Baxter (BAX) | United States | $14.728B | 11.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.993B | 24.33 |
| Lantheus Holdings (LNTH) | United States | $5.626B | 14.19 |
| Perrigo (PRGO) | Ireland | $3.785B | 9.59 |
| Prestige Consumer Healthcare (PBH) | United States | $3.780B | 16.89 |
| Haemonetics (HAE) | United States | $3.628B | 16.52 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.424B | 28.45 |
| ICU Medical (ICUI) | United States | $3.253B | 23.99 |
| QuidelOrtho (QDEL) | United States | $2.052B | 14.11 |
| LeMaitre Vascular (LMAT) | United States | $1.891B | 42.26 |
| AtriCure (ATRC) | United States | $1.521B | 0.00 |
| Acuren (TIC) | United States | $1.395B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.389B | 31.24 |
| Phibro Animal Health (PAHC) | United States | $1.248B | 15.96 |
| AdaptHealth (AHCO) | United States | $1.244B | 12.63 |
| Neogen (NEOG) | United States | $1.170B | 14.97 |
| BioLife Solutions (BLFS) | United States | $1.050B | 0.00 |
| InMode (INMD) | Israel | $0.930B | 9.37 |
| Curaleaf Holdings (CURLF) | Canada | $0.771B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.766B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.695B | 0.00 |
| Owens & Minor (OMI) | United States | $0.627B | 5.21 |
| Evolus (EOLS) | United States | $0.611B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.584B | 0.00 |
| CeriBell (CBLL) | United States | $0.583B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Surmodics (SRDX) | United States | $0.441B | 0.00 |
| SNDL (SNDL) | Canada | $0.365B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.349B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.337B | 12.38 |
| Cresco Labs (CRLBF) | United States | $0.323B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.298B | 0.00 |
| Quanterix (QTRX) | United States | $0.294B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.47 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 74.83 |
| ZimVie (ZIMV) | United States | $0.251B | 11.39 |
| Verano Holdings (VRNOF) | United States | $0.235B | 0.00 |
| Brainsway (BWAY) | Israel | $0.233B | 61.55 |
| Biote (BTMD) | United States | $0.223B | 6.28 |
| Omeros (OMER) | United States | $0.214B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.194B | 0.00 |
| High Tide (HITI) | Canada | $0.191B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 14.93 |
| Vireo Growth (VREOF) | United States | $0.163B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.117B | 0.00 |
| MacroGenics (MGNX) | United States | $0.102B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 12.68 |
| Jushi Holdings (JUSHF) | United States | $0.090B | 0.00 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.081B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Agape ATP (ATPC) | $0.074B | 0.00 | |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Zynex (ZYXI) | United States | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Nephros (NEPH) | United States | $0.038B | 51.43 |
| United-Guardian (UG) | United States | $0.037B | 12.89 |
| Safety Shot (SHOT) | United States | $0.034B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |